Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency
April 06 2017 - 10:00AM
Business Wire
Company Receives EPA Honor for 12th
Consecutive Year
Merck (NYSE:MRK), known as MSD outside the United States and
Canada, announced today that it has received an ENERGY STAR 2017
Partner of the Year – Sustained Excellence Award from the U.S.
Environmental Protection Agency (EPA) for its continued improvement
of energy performance and leadership in energy management in both
the pharmaceutical and industrial sectors.
Merck has been an ENERGY STAR partner since 1995 and recognized
by the EPA for 12 consecutive years, two times as Partner of the
Year and now a 10th time for Sustained Excellence.
“Merck is proud of the continued efforts and commitment of our
employees who have helped the company achieve this honor 12 years
in a row,” said Don Watson, vice president, global workplace &
enterprise services, Merck. “Even with the success of achieving our
energy goals, we continue to look for opportunities to be an
industry leader with our sustainability programs.”
The award recognizes one Merck manufacturing site that has
achieved ENERGY STAR rankings in the top 25 percent of
pharmaceutical plant energy performance nationwide: Las Piedras,
Puerto Rico.
Also achieving certification this year were office buildings in
Cokesbury, Whitehouse Station and Branchburg, N.J., as well as an
office building in Upper Gwynedd, Pa.
For more information about Merck's ongoing environmental and
energy conservation efforts, please visit
www.merckresponsibility.com.
About ENERGY STAR
ENERGY STAR is the simple choice for energy efficiency. For more
than 20 years, people across America have looked to EPA’s ENERGY
STAR program for guidance on how to save energy, save money, and
protect the environment. Behind each blue label is a product,
building, or home that is independently certified to use less
energy and cause fewer of the emissions that contribute to climate
change. Today, ENERGY STAR is the most widely recognized symbol for
energy efficiency in the world, helping families and businesses
save $362 billion on utility bills, while reducing greenhouse gas
emissions by more than 2.4 billion metric tons since 1992. Join the
millions who are already making a difference at energystar.gov.
About Merck
For over a century, Merck has been a global health care leader
working to help the world be well. Merck is known as MSD outside
the United States and Canada. Through our prescription medicines,
vaccines, biologic therapies, and animal health products, we work
with customers and operate in more than 140 countries to deliver
innovative health solutions. We also demonstrate our commitment to
increasing access to health care through far-reaching policies,
programs and partnerships. For more information,
visit www.merck.com and connect with us
on Twitter, Facebook, YouTube and LinkedIn.
Forward-Looking Statement of Merck & Co., Inc.,
Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J.,
USA (the “company”) includes “forward-looking statements” within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. These statements are
based upon the current beliefs and expectations of the company’s
management and are subject to significant risks and uncertainties.
If underlying assumptions prove inaccurate or risks or
uncertainties materialize, actual results may differ materially
from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general
industry conditions and competition; general economic factors,
including interest rate and currency exchange rate fluctuations;
the impact of pharmaceutical industry regulation and health care
legislation in the United States and internationally; global trends
toward health care cost containment; technological advances, new
products and patents attained by competitors; challenges inherent
in new product development, including obtaining regulatory
approval; the company’s ability to accurately predict future market
conditions; manufacturing difficulties or delays; financial
instability of international economies and sovereign risk;
dependence on the effectiveness of the company’s patents and other
protections for innovative products; and the exposure to
litigation, including patent litigation, and/or regulatory
actions.
The company undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events or otherwise. Additional factors that could cause
results to differ materially from those described in the
forward-looking statements can be found in the company’s 2016
Annual Report on Form 10-K and the company’s other filings with the
Securities and Exchange Commission (SEC) available at the SEC’s
Internet site (www.sec.gov).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170406005079/en/
MerckMedia:Claire Gillespie, 267-305-0932orInvestors:Amy Klug,
908-740-1898
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024